LOIS M RAMONDETTA to Infusions, Intravenous
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Infusions, Intravenous.
Connection Strength
0.209
-
Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community Hospital. J Oncol Pract. 2019 06; 15(6):e576-e582.
Score: 0.133
-
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07; 390(10103):1654-1663.
Score: 0.030
-
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015 Mar; 16(3):301-11.
Score: 0.025
-
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol. 2013 May; 129(2):304-9.
Score: 0.022